Search Results - "Waubant, Emmanuelle"

Two-armed active comparator trials are unethical in paediatric multiple sclerosis – Commentary by Waubant, Emmanuelle

Get full text

The gut microbiome in human neurological disease: A review by Tremlett, Helen, Bauer, Kylynda C., Appel‐Cresswell, Silke, Finlay, Brett B., Waubant, Emmanuelle

“…Almost half the cells and 1% of the unique genes found in our bodies are human, the rest are from microbes, predominantly bacteria, archaea, fungi, and…”
Get full text

The COVID-19 pandemic and the use of MS disease-modifying therapies by Giovannoni, Gavin, Hawkes, Chris, Lechner-Scott, Jeannette, Levy, Michael, Waubant, Emmanuelle, Gold, Julian

Get full text

Trial of Fingolimod versus Interferon Beta-1a in Pediatric Multiple Sclerosis by Chitnis, Tanuja, Arnold, Douglas L, Banwell, Brenda, Brück, Wolfgang, Ghezzi, Angelo, Giovannoni, Gavin, Greenberg, Benjamin, Krupp, Lauren, Rostásy, Kevin, Tardieu, Marc, Waubant, Emmanuelle, Wolinsky, Jerry S, Bar-Or, Amit, Stites, Tracy, Chen, Yu, Putzki, Norman, Merschhemke, Martin, Gärtner, Jutta

“…In 215 patients with a median age of 16 years, fingolimod was superior to interferon beta-1a in reducing relapses of multiple sclerosis and the accumulation of…”
Get full text

Implementing the 2017 McDonald criteria for the diagnosis of multiple sclerosis by Zipp, Frauke, Oh, Jiwon, Fragoso, Yara Dadalti, Waubant, Emmanuelle

“…The latest revision of the McDonald criteria for the diagnosis of multiple sclerosis (MS) was published online in 2017. New features of the criteria, which…”
Get full text

Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria by Polman, Chris H., Reingold, Stephen C., Banwell, Brenda, Clanet, Michel, Cohen, Jeffrey A., Filippi, Massimo, Fujihara, Kazuo, Havrdova, Eva, Hutchinson, Michael, Kappos, Ludwig, Lublin, Fred D., Montalban, Xavier, O'Connor, Paul, Sandberg-Wollheim, Magnhild, Thompson, Alan J., Waubant, Emmanuelle, Weinshenker, Brian, Wolinsky, Jerry S.

“…New evidence and consensus has led to further revision of the McDonald Criteria for diagnosis of multiple sclerosis. The use of imaging for demonstration of…”
Get full text

Gut Microbiota in Multiple Sclerosis: Possible Influence of Immunomodulators by Cantarel, Brandi L., Waubant, Emmanuelle, Chehoud, Christel, Kuczynski, Justin, DeSantis, Todd Z., Warrington, Janet, Venkatesan, Arun, Fraser, Claire M., Mowry, Ellen M.

“…Objectives Differences in gut bacteria have been described in several autoimmune disorders. In this exploratory pilot study, we compared gut bacteria in…”
Get full text

Rituximab in relapsing and progressive forms of multiple sclerosis: a systematic review by Castillo-Trivino, Tamara, Braithwaite, Dejana, Bacchetti, Peter, Waubant, Emmanuelle

“…Rituximab is an anti-CD20 monoclonal antibody approved for non Hodgkin lymphoma and rheumatoid arthritis. It is being considered for the treatment of MS. To…”
Get full text

Environmental and genetic risk factors for MS: an integrated review by Waubant, Emmanuelle, Lucas, Robyn, Mowry, Ellen, Graves, Jennifer, Olsson, Tomas, Alfredsson, Lars, Langer‐Gould, Annette

“…Recent findings have provided a molecular basis for the combined contributions of multifaceted risk factors for the onset of multiple sclerosis (MS). MS…”
Get full text

Design recommendations for studies that evaluate multiple sclerosis fatigue interventions by Ghajarzadeh, Mahsa, Waubant, Emmanuelle, Nourbakhsh, Bardia

Get full text

Differential diagnosis of suspected multiple sclerosis: an updated consensus approach by Solomon, Andrew J, Arrambide, Georgina, Brownlee, Wallace J, Flanagan, Eoin P, Amato, Maria Pia, Amezcua, Lilyana, Banwell, Brenda L, Barkhof, Frederik, Corboy, John R, Correale, Jorge, Fujihara, Kazuo, Graves, Jennifer, Harnegie, Mary Pat, Hemmer, Bernhard, Lechner-Scott, Jeannette, Marrie, Ruth Ann, Newsome, Scott D, Rocca, Maria A, Royal, Walter, Waubant, Emmanuelle L, Yamout, Bassem, Cohen, Jeffrey A

“…Accurate diagnosis of multiple sclerosis requires careful attention to its differential diagnosis—many disorders can mimic the clinical manifestations and…”
Get full text

Preventing Multiple Sclerosis: The Pediatric Perspective by Hardy, Duriel, Chitnis, Tanuja, Waubant, Emmanuelle, Banwell, Brenda

“…Pediatric-onset multiple sclerosis (MS) is a predominantly relapsing-remitting neuroinflammatory disorder characterized by frequent relapses and high magnetic…”
Get full text

Susceptibility-based imaging aids accurate distinction of pediatric-onset MS from myelin oligodendrocyte glycoprotein antibody-associated disease by Sacco, Simone, Virupakshaiah, Akash, Papinutto, Nico, Schoeps, Vinicius A, Akula, Amit, Zhao, Haojun, Arona, Jennifer, Stern, William A, Chong, Janet, Hart, Janace, Zamvil, Scott S, Sati, Pascal, Henry, Roland G, Waubant, Emmanuelle

“…Background: Myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease (MOGAD) and pediatric-onset multiple sclerosis (POMS) share clinical and…”
Get full text

Acute Flaccid Myelitis of Unknown Etiology in California, 2012-2015 by Van Haren, Keith, Ayscue, Patrick, Waubant, Emmanuelle, Clayton, Anna, Sheriff, Heather, Yagi, Shigeo, Glenn-Finer, Rose, Padilla, Tasha, Strober, Jonathan B, Aldrovandi, Grace, Wadford, Debra A, Chiu, Charles Y, Xia, Dongxiang, Harriman, Kathleen, Watt, James P, Glaser, Carol A

“…IMPORTANCE: There has been limited surveillance for acute flaccid paralysis in North America since the regional eradication of poliovirus. In 2012, the…”
Get full text

A validation study for remote testing of cognitive function in multiple sclerosis by Barcellos, Lisa F, Horton, Mary, Shao, Xiaorong, Bellesis, Kalliope H, Chinn, Terrence, Waubant, Emmanuelle, Bakshi, Nandini, Marcus, Jackie, Benedict, Ralph HB, Schaefer, Catherine

“…Objectives: Determine the validity and reliability of a remote, technician-guided cognitive assessment for multiple sclerosis (MS), incorporating the Symbol…”
Get full text

Several serum lipid metabolites are associated with relapse risk in pediatric-onset multiple sclerosis by Virupakshaiah, Akash, Ladakis, Dimitrios C, Nourbakhsh, Bardia, Bhargava, Pavan, Dilwali, Sonam, Schoeps, Vinicius, Borkowski, Kamil, Newman, John W, Waubant, Emmanuelle

“…Background: The circulating metabolome is altered in multiple sclerosis (MS), but its prognostic capabilities have not been extensively explored. Lipid…”
Get full text

Rituximab in patients with pediatric multiple sclerosis and other demyelinating disorders of the CNS: Practical considerations by Ghezzi, Angelo, Banwell, Brenda, Bar-Or, Amit, Chitnis, Tanuja, Dale, Russell C, Gorman, Mark, Kornek, Barbara, Krupp, Lauren, Krysko, Kristen M, Nosadini, Margherita, Rostasy, Kevin, Salzer, Jonatan, Schreiner, Teri, Tenembaum, Silvia, Waubant, Emmanuelle

“…Anti-CD20 therapies have established efficacy in the treatment of immune-mediated neurological and non-neurological diseases. Rituximab, one of the first…”
Get full text

Using an animal model to predict the effective human dose for oral multiple sclerosis drugs by Liu, Wei, Yu, Zhiheng, Wang, Ziyu, Waubant, Emmanuelle L., Zhai, Suodi, Benet, Leslie Z.

“…The objective of this study was to determine the potential usefulness of an animal model to predict the appropriate dose of newly developed drugs for treating…”
Get full text

Rituximab in relapsing‐remitting multiple sclerosis: A 72‐week, open‐label, phase I trial by Bar‐Or, Amit, Calabresi, Peter A. J., Arnold, Douglas, Markowitz, Clyde, Shafer, Stuart, Kasper, Lloyd H., Waubant, Emmanuelle, Gazda, Suzanne, Fox, Robert J., Panzara, Michael, Sarkar, Neena, Agarwal, Sunil, Smith, Craig H.

“…We evaluated the safety, tolerability, pharmacodynamics, and activity of B‐cell depletion with rituximab in patients with relapsing‐remitting multiple…”
Get full text

Seafood, fatty acid biosynthesis genes, and multiple sclerosis susceptibility by Langer-Gould, Annette, Black, Lucinda J, Waubant, Emmanuelle, Smith, Jessica B, Wu, Jun, Gonzales, Edlin G, Shao, Xiaorong, Koebnick, Corinna, Lucas, Robyn M, Xiang, Anny, Barcellos, Lisa F

“…Background: The role of omega-3 fatty acid in multiple sclerosis (MS) susceptibility is unclear. Objective: To determine whether fish/seafood intake or genetic…”
Get full text